BIAFWNasdaq

bioAffinity Technologies, Inc.

Services-Commercial Physical & Biological Research · DE · CIK 1712762

Develops noninvasive diagnostic tests for early-stage lung cancer and other lung diseases using flow cytometry and AI

red 8-K · 90d

—

Market cap

$0.14

Last close

-10.5%

-29.9%

997

Volume

Price · last 18 sessions-47.9%

May 4L $0.14 · H $0.31Jun 17

168

Total filings

Jun 18, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance